Chemical genetics uncovers promising anti-COVID compounds
Coronavirus
Compuscript Ltd Sep 25 2024 This new article publication from Acta Pharmaceutica Sinica B , discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics. There are only eight approved small molecule antiviral drugs for treating COVID-19. Among them, four are nucleotide analogues (remdesivir, JT001, molnupiravir, and azvudine), while the other four are protease inhibitors (nirmatrelvir, ensitrelvir, leritrelvir, and simnotrelvir-ritonavir). Antiviral
din zilele anterioare